ShangPharma Innovation | Charles Yang, Ph.D.
15928
team_member-template-default,single,single-team_member,postid-15928,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,qode-content-sidebar-responsive,qode-theme-ver-10.1.1,builder-parallax-scrolling-active,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

Charles Yang, Ph.D.

Dr. Charles Yang has decades of international experience in the biopharmaceutical industry and academia. For the last seven years, Dr. Yang was the vice president of biology, and head of neuroscience, at Shanghai ChemPartner, where he managed a global partnership in the biology CRO business. Previously, Dr. Yang was a senior neuroscience discovery scientist at Eli Lilly & Co. for twelve years, leading discovery efforts in novel CNS therapeutics targeting neuropsychiatric disorders. Prior to joining the industry, Dr. Yang had a distinguished academic career in neuroscience at the University of British Columbia. He received his Ph.D. in system neurophysiology from the University of Western Ontario, and completed his post-doctoral work at McGill University and Ottawa Civic Hospital in Canada.

d
c